|
TJP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.577200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.749600E-01 |
| Normal-vs-Stage2 |
4.685800E-01 |
| Normal-vs-Stage3 |
1.999650E-01 |
| Normal-vs-Stage4 |
5.910500E-02 |
| Stage1-vs-Stage2 |
5.477200E-01 |
| Stage1-vs-Stage3 |
1.904190E-01 |
| Stage1-vs-Stage4 |
3.852000E-02 |
| Stage2-vs-Stage3 |
7.440400E-01 |
| Stage2-vs-Stage4 |
3.984600E-01 |
| Stage3-vs-Stage4 |
4.894800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.877600E-01 |
| Normal-vs-AfricanAmerican |
6.393800E-01 |
| Normal-vs-Asian |
5.632600E-01 |
| Caucasian-vs-AfricanAmerican |
3.313800E-01 |
| Caucasian-vs-Asian |
9.977000E-01 |
| AfricanAmerican-vs-Asian |
3.836200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.924600E-01 |
| Normal-vs-Female |
4.858800E-01 |
| Male-vs-Female |
5.247600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.752000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.846800E-01 |
| Normal-vs-Age(61-80Yrs) |
3.065500E-02 |
| Normal-vs-Age(81-100Yrs) |
1.263170E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.288580E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.803600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.758000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.002010E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.221000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.797600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.211820E-01 |
| Classical-VS-Follicular |
4.44950000000333E-05 |
| Classical-VS-Other |
9.548400E-02 |
| Classical-VS-Normal |
6.748600E-01 |
| Tall-VS-Follicular |
2.890000E-01 |
| Tall-VS-Other |
3.184600E-01 |
| Tall-VS-Normal |
2.408400E-01 |
| Follicular-VS-Other |
7.479200E-01 |
| Follicular-VS-Normal |
9.395300E-03 |
| Other-VS-Normal |
1.052010E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.415400E-01 |
| Normal-vs-N1 |
2.226600E-01 |
| N0-vs-N1 |
9.423800E-01 |
|
|
